Burfiralimab, CAS 2460809-80-5

Product Description: Burfiralimab (hzVSF-v13) is a monoclonal IgG4 antibody against vimentin expressed on the surface of virus-infected cells, with broad-spectrum antiviral activity and anti-inflammatory effects against virus-induced inflammation. Burfiralimab can be used in severe COVID-19 studies[1].

Applications: COVID-19-anti-virus

Formula: N/A

References: [1]Prasenohadi Prasenohadi, et al. Double-Blind, Randomized, Placebo-Controlled Study on hzVSF-v13, a Novel Anti-Vimentin Monoclonal Antibody Drug as Add-on Standard of Care in the Management of Patients with Moderate to Severe COVID-19. J Clin Med. 2022 May 24;11(11):2961.

CAS Number: 2460809-80-5

Molecular Weight: N/A

Compound Purity: 95.20

Research Area: Infection; Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related;SARS-CoV

• SKU: MEXHY-P99490-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99490-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated